At the COFONI closing symposium, researchers presented findings from 38 projects—and drew lessons for future pandemics.

BaKlimON Project: Three universities in Hanover are investigating the effects on humans, animals, and plants.

MHH researchers are studying biological aging processes in MMA fighters.

MHH researchers are developing a customisable glaucoma implant. It is designed to significantly reduce the risk of scarring and blindness.

An international Phase 2 clinical trial led by MHH demonstrates the beneficial effects of the microRNA blocker in severely damaged hearts.

A 3.8-billion-year-old quantum machine controls our immune system: MHH research team discovers ancient mechanism that still works.

MHH biochemist is researching alternatives to antibiotics and has received two million euros from the European Union.

MHH researchers are developing bioreactors to produce millions of human immune cells. The method opens up opportunities for research and therapy.

Researchers are investigating previously little-noticed types of immune cells and their role in virus defense.

A research team in Lower Saxony is developing more precise diagnostic methods for collagenoses. “Zukunft.niedersachsen” is providing 2.7 million euros…